Theranostic Nanoparticles for the Management of Thrombosis

Overview

Journal Theranostics

Date 2022 Apr 11

PMID 35401833

Authors

Peije Russell

Christoph Eugen Hagemeyer

Lars Esser

Nicolas Hans Voelcker

Affiliations

Soon will be listed here.

Abstract

Acute thrombosis and thromboembolisms are one of the leading causes of mortality and morbidity in both developed and developing countries, placing a huge burden on health and economic systems. Early diagnosis is critical but currently limited in accuracy and hampered by a narrow time frame, where the short therapeutic window also severely restricts treatment options. Additionally, clinically used antithrombotics and thrombolytics suffer from severe side effects and are limited in efficacy by a short half-life and susceptibility to degradation. The use of systems containing both diagnostic and therapeutic moieties, known as theranostics, can potentially improve patient outcomes by increasing the precision and efficacy of diagnosis and treatment, enabling personalised and precision medicine. Leveraging nanomedicine may further improve treatment by improving the system's pharmacokinetic properties including controlled drug delivery. This review provides an overview of the development of such theranostic nanoparticle systems, with a focus on approaches that may be utilised to usher this field towards clinical use.

Citing Articles

Overview of Venous Thromboembolism and Emerging Therapeutic Technologies Based on Nanocarriers-Mediated Drug Delivery Systems.

Salavati M, Arabshomali A, Nouranian S, Shariat-Madar Z Molecules. 2024; 29(20).

PMID: 39459251 PMC: 11510185. DOI: 10.3390/molecules29204883.

Progress of nanomaterials in the treatment of thrombus.

Shen Y, Yu Y, Zhang X, Hu B, Wang N Drug Deliv Transl Res. 2023; 14(5):1154-1172.

PMID: 38006448 DOI: 10.1007/s13346-023-01478-6.

RGD peptide modified RBC membrane functionalized biomimetic nanoparticles for thrombolytic therapy.

Xu Z, Huang J, Zhang T, Xu W, Liao X, Wang Y J Mater Sci Mater Med. 2023; 34(4):18.

PMID: 37043085 PMC: 10097782. DOI: 10.1007/s10856-023-06719-1.

Biogenic Selenium Nanoparticles in Biomedical Sciences: Properties, Current Trends, Novel Opportunities and Emerging Challenges in Theranostic Nanomedicine.

Zambonino M, Quizhpe E, Mouheb L, Rahman A, Agathos S, Dahoumane S Nanomaterials (Basel). 2023; 13(3).

PMID: 36770385 PMC: 9921003. DOI: 10.3390/nano13030424.

Biomaterials-Enabled Antithrombotics: Recent Advances and Emerging Strategies.

Hale M, Medina S Mol Pharm. 2022; 19(12):4453-4465.

PMID: 36149250 PMC: 9728464. DOI: 10.1021/acs.molpharmaceut.2c00626.

References

Dadfar S, Roemhild K, Drude N, von Stillfried S, Knuchel R, Kiessling F . Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications. Adv Drug Deliv Rev. 2019; 138:302-325. PMC: 7115878. DOI: 10.1016/j.addr.2019.01.005. View

Paszkowiak J, Dardik A . Arterial wall shear stress: observations from the bench to the bedside. Vasc Endovascular Surg. 2003; 37(1):47-57. DOI: 10.1177/153857440303700107. View

Vassaux G, Groot-Wassink T . In Vivo Noninvasive Imaging for Gene Therapy. J Biomed Biotechnol. 2003; 2003(2):92-101. PMC: 323954. DOI: 10.1155/S1110724303209050. View

Ryu J, Rafalski V, Meyer-Franke A, Adams R, Poda S, Rios Coronado P . Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration. Nat Immunol. 2018; 19(11):1212-1223. PMC: 6317891. DOI: 10.1038/s41590-018-0232-x. View

Linkins L, Takach Lapner S . Review of D-dimer testing: Good, Bad, and Ugly. Int J Lab Hematol. 2017; 39 Suppl 1:98-103. DOI: 10.1111/ijlh.12665. View

Molina C, Barreto A, Tsivgoulis G, Sierzenski P, Malkoff M, Rubiera M . Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial. Ann Neurol. 2009; 66(1):28-38. DOI: 10.1002/ana.21723. View

Owens 3rd A, Lu Y, Whinna H, Gachet C, Fay W, Mackman N . Towards a standardization of the murine ferric chloride-induced carotid arterial thrombosis model. J Thromb Haemost. 2011; 9(9):1862-3. DOI: 10.1111/j.1538-7836.2011.04287.x. View

Moore A, Wachsmann J, Chamarthy M, Panjikaran L, Tanabe Y, Rajiah P . Imaging of acute pulmonary embolism: an update. Cardiovasc Diagn Ther. 2018; 8(3):225-243. PMC: 6039809. DOI: 10.21037/cdt.2017.12.01. View

Liu C, Hsu H, Chen J, Wu T, Ma Y . Thrombolysis induced by intravenous administration of plasminogen activator in magnetoliposomes: dual targeting by magnetic and thermal manipulation. Nanomedicine. 2019; 20:101992. DOI: 10.1016/j.nano.2019.03.014. View

10.

Wise J . Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots. BMJ. 2021; 372:n699. DOI: 10.1136/bmj.n699. View

11.

Mitcham T, Dextraze K, Taghavi H, Melancon M, Bouchard R . Photoacoustic imaging driven by an interstitial irradiation source. Photoacoustics. 2015; 3(2):45-54. PMC: 4519807. DOI: 10.1016/j.pacs.2015.02.002. View

12.

Nakatsuka M, Mattrey R, Esener S, Cha J, Goodwin A . Aptamer-crosslinked microbubbles: smart contrast agents for thrombin-activated ultrasound imaging. Adv Mater. 2012; 24(45):6010-6. PMC: 3626403. DOI: 10.1002/adma.201201484. View

13.

. Nanomedicine and the COVID-19 vaccines. Nat Nanotechnol. 2020; 15(12):963. PMC: 7692425. DOI: 10.1038/s41565-020-00820-0. View

14.

Gunawan S, Kempe K, Bonnard T, Cui J, Alt K, Law L . Multifunctional Thrombin-Activatable Polymer Capsules for Specific Targeting to Activated Platelets. Adv Mater. 2015; 27(35):5153-7. DOI: 10.1002/adma.201502243. View

15.

Bhat R, Ribes A, Mas N, Aznar E, Sancenon F, Marcos M . Thrombin-Responsive Gated Silica Mesoporous Nanoparticles As Coagulation Regulators. Langmuir. 2016; 32(5):1195-200. DOI: 10.1021/acs.langmuir.5b04038. View

16.

Ferro J, Bousser M, Canhao P, Coutinho J, Crassard I, Dentali F . European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis - Endorsed by the European Academy of Neurology. Eur Stroke J. 2019; 2(3):195-221. PMC: 6454824. DOI: 10.1177/2396987317719364. View

17.

Yang J, Cho K, Kim J, Kim S, Kim C, You G . Wall shear stress in hypertensive patients is associated with carotid vascular deformation assessed by speckle tracking strain imaging. Clin Hypertens. 2016; 20:10. PMC: 4750791. DOI: 10.1186/2056-5909-20-10. View

18.

van Dam L, van Walderveen M, Kroft L, Kruyt N, Wermer M, van Osch M . Current imaging modalities for diagnosing cerebral vein thrombosis - A critical review. Thromb Res. 2020; 189:132-139. DOI: 10.1016/j.thromres.2020.03.011. View

19.

Zenych A, Fournier L, Chauvierre C . Nanomedicine progress in thrombolytic therapy. Biomaterials. 2020; 258:120297. DOI: 10.1016/j.biomaterials.2020.120297. View

20.

Huang Y, Yu L, Ren J, Gu B, Longstaff C, Hughes A . An activated-platelet-sensitive nanocarrier enables targeted delivery of tissue plasminogen activator for effective thrombolytic therapy. J Control Release. 2019; 300:1-12. DOI: 10.1016/j.jconrel.2019.02.033. View